Xi'an International Medical Investment Future Growth
Future criteria checks 5/6
Xi'an International Medical Investment is forecast to grow earnings and revenue by 104.9% and 21.6% per annum respectively. EPS is expected to grow by 128.4% per annum. Return on equity is forecast to be 8.2% in 3 years.
Key information
104.9%
Earnings growth rate
128.4%
EPS growth rate
| Healthcare earnings growth | 23.1% |
| Revenue growth rate | 21.6% |
| Future return on equity | 8.2% |
| Analyst coverage | Low |
| Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt
Nov 21
After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar
Oct 01Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt
Jul 16Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)
Jun 20Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?
Mar 25Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,761 | 381 | N/A | 1,206 | 1 |
| 12/31/2025 | 7,077 | 320 | N/A | 1,351 | 2 |
| 12/31/2024 | 5,478 | 100 | N/A | 652 | 1 |
| 9/30/2024 | 4,880 | -358 | 419 | 1,022 | N/A |
| 6/30/2024 | 4,829 | -320 | 504 | 1,203 | N/A |
| 3/31/2024 | 4,732 | -399 | 510 | 1,084 | N/A |
| 12/31/2023 | 4,618 | -368 | 325 | 1,087 | N/A |
| 9/30/2023 | 4,141 | -572 | 116 | 1,153 | N/A |
| 6/30/2023 | 3,853 | -803 | 59 | 1,074 | N/A |
| 3/31/2023 | 3,465 | -823 | -650 | 891 | N/A |
| 1/1/2023 | 2,711 | -1,177 | -727 | 461 | N/A |
| 9/30/2022 | 2,786 | -1,064 | -940 | 294 | N/A |
| 6/30/2022 | 2,683 | -1,058 | -1,269 | 176 | N/A |
| 3/31/2022 | 2,594 | -1,068 | -832 | 184 | N/A |
| 12/31/2021 | 2,921 | -822 | -1,203 | 456 | N/A |
| 9/30/2021 | 2,583 | -41 | -1,096 | 374 | N/A |
| 6/30/2021 | 2,273 | 30 | -1,174 | 379 | N/A |
| 3/31/2021 | 1,964 | 52 | -1,401 | 252 | N/A |
| 12/31/2020 | 1,607 | 45 | -1,297 | 41 | N/A |
| 9/30/2020 | 1,391 | -882 | -2,168 | -285 | N/A |
| 6/30/2020 | 1,188 | -753 | -2,627 | -422 | N/A |
| 3/31/2020 | 1,046 | -622 | -3,378 | -313 | N/A |
| 12/31/2019 | 991 | -404 | -3,647 | -34 | N/A |
| 9/30/2019 | 896 | -68 | -3,460 | 128 | N/A |
| 6/30/2019 | 872 | -19 | -3,775 | -554 | N/A |
| 3/31/2019 | 1,108 | 2,193 | -3,010 | -622 | N/A |
| 12/31/2018 | 2,039 | 2,184 | -2,471 | -772 | N/A |
| 9/30/2018 | 2,973 | 2,244 | -1,607 | -496 | N/A |
| 6/30/2018 | 3,617 | 2,280 | N/A | 203 | N/A |
| 3/31/2018 | 4,130 | 152 | N/A | 424 | N/A |
| 12/31/2017 | 4,060 | 195 | N/A | 384 | N/A |
| 9/30/2017 | 4,024 | 190 | N/A | 335 | N/A |
| 6/30/2017 | 3,984 | 191 | N/A | 395 | N/A |
| 3/31/2017 | 3,944 | 214 | N/A | 415 | N/A |
| 12/31/2016 | 3,931 | 202 | N/A | 439 | N/A |
| 9/30/2016 | 3,872 | 260 | N/A | 362 | N/A |
| 6/30/2016 | 3,866 | 217 | N/A | 350 | N/A |
| 3/31/2016 | 3,866 | 197 | N/A | 260 | N/A |
| 12/31/2015 | 3,900 | 241 | N/A | 274 | N/A |
| 9/30/2015 | 3,927 | 328 | N/A | 262 | N/A |
| 6/30/2015 | 3,960 | 369 | N/A | 292 | N/A |
| 3/31/2015 | 3,929 | 382 | N/A | 318 | N/A |
| 12/31/2014 | 3,883 | 350 | N/A | 306 | N/A |
| 9/30/2014 | 3,786 | 213 | N/A | 399 | N/A |
| 6/30/2014 | 3,645 | 168 | N/A | 337 | N/A |
| 3/31/2014 | 3,604 | 142 | N/A | 241 | N/A |
| 12/31/2013 | 3,566 | 122 | N/A | 328 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000516 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: 000516 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 000516 is expected to become profitable in the next 3 years.
Revenue vs Market: 000516's revenue (21.6% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 000516's revenue (21.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 000516's Return on Equity is forecast to be low in 3 years time (8.2%).